-
Trevi Therapeutics, Inc. (NASDAQ:TRVI) Given Consensus Rating of "Buy" by Analysts
Source: Buzz FX / 13 Nov 2024 04:10:18 America/Chicago
Trevi Therapeutics, Inc. (NASDAQ:TRVI) Given Consensus Rating of "Buy" by Analysts Written by MarketBeat November 13, 2024 Share Link copied to clipboard. Shares of Trevi Therapeutics, Inc. ( NASDAQ:TRVI - Get Free Report ) have been assign
Read more...